Assay result

Ipamorelin from Limitless Life Nootropics

Fail — multiple

Testing lab

Finnrick Analytics

Sample source

Third-party public COA

Chain of custody

Finnrick Analytics public per-vendor rating. Limitless Life Nootropics rated D (Poor) on Ipamorelin across 4 samples tested February 13-19, 2025. Tentative rating per Finnrick. Failing third-party signal.

Third-party public COA — attribution

This result was not produced by Open Assay. It is a publicly published COA from Finnrick Analytics, cited here under the same pass/fail thresholds we apply to our own assays. Credit and traffic belong to the originating lab.

↗ View source report